|2.||Pancreatic Neoplasms (Pancreatic Cancer)
|4.||Pancreatic Diseases (Pancreatic Disease)
|1.||Pezzilli, Raffaele: 10 articles (11/2015 - 05/2002)|
|2.||Paulo, Joao A: 8 articles (10/2015 - 12/2011)|
|3.||Conwell, Darwin L: 7 articles (10/2013 - 06/2002)|
|4.||Brand, Randall E: 5 articles (11/2015 - 12/2004)|
|5.||Wallace, Michael B: 5 articles (01/2014 - 09/2005)|
|6.||Banks, Peter A: 5 articles (10/2013 - 12/2011)|
|7.||Steen, Hanno: 5 articles (10/2013 - 12/2011)|
|8.||Friess, H: 5 articles (05/2013 - 02/2000)|
|9.||Gullo, Lucio: 5 articles (07/2008 - 05/2002)|
|10.||Yamaguchi, Koji: 5 articles (01/2006 - 06/2004)|
01/01/1964 - "[RENAL CLEARANCE OF AMYLASE IN THE NORMAL STATE AND IN PANCREATIC DISEASES]."
12/01/1954 - "A correlative study of the external pancreatic secretion, the plasma antithrombin titer, the blood amylase concentration, and the serum mucoprotein level in patients with and without pancreatic disease."
11/14/1952 - "[Curves of lipases and amylases in the blood produced by carbaminoylcholine; value in the study of chronic pancreatic diseases]."
01/01/2001 - "Although serum amylase level is an important diagnostic factor in certain salivary and pancreatic diseases, little information is available regarding the mechanism by which parotid amylase reaches the circulatory system. "
08/01/1997 - "Total amylase is a poor indicator of pancreatic disease in HIV infected outpatients. "
06/01/1998 - "The results of this study, requiring confirmation, suggest that the polymorphism of GSTM1 and NAT1 enzymes may be associated with a modest increase in susceptibility to pancreatic diseases."
04/01/1960 - "The combined study of serum enzymes and duodenal contents in the diagnosis of pancreatic disease."
01/01/2013 - "Asymptomatic elevation in serum pancreatic enzymes in the absence of pancreatic disease is reported in the literature and defined as "Gullo's syndrome," but nobody of the subjects studied had been treated in the past with pancreatotoxic drugs. "
10/01/2012 - "An increase in serum levels of pancreatic enzymes is a well-known manifestation of pancreatic disease, especially of inflammatory or neoplastic nature, even if several extrapancreatic diseases can equally cause that increase. "
10/01/2009 - "[Elevated pancreatic enzymes without evident pancreatic disease]."
01/01/1991 - "The present study evaluated serum ribonuclease activity (SRA) in patients with inflammatory and neoplastic pancreatic diseases. "
04/01/1983 - "[Studies on ribonuclease in the pancreatic juice of patient with pancreatic disease. "
06/01/1981 - "[Studies on ribonucleases in the pancreatic juice of patients with pancreatic disease. "
01/01/1991 - "RNase was also increased in a high number of patients with pancreatic diseases, but was not correlated with pancreatic damage. "
01/01/1991 - "Serum ribonuclease activity in the diagnosis of pancreatic disease."
|4.||Lipase (Acid Lipase)FDA Link
08/01/1988 - "Fractional urinary clearance of immunoreactive lipase in chronic pancreatic disease."
01/16/2014 - "We followed up this patient for two years with blood tests every six months and she did not show any signs or symptoms of pancreatic disease, except for the high level of lipase serum. "
10/01/2013 - "Severe pancreatic dysfunction but compensated nutritional status in monogenic pancreatic disease caused by carboxyl-ester lipase mutations."
01/01/2012 - "To determine associations between postprandial serum triglyceride concentrations and canine pancreatic lipase immunoreactivity (cPLI) concentrations or pancreatic disease. "
07/01/2006 - "A diagnosis of pancreatic disease was made on the findings of marked elevations of serum lipase concentrations and ultrasonographic identification of pancreatic masses in both cases. "
|5.||Pancreatic Elastase (Elastase)IBA
01/01/2003 - "The measurement of fecal elastase 1 concentrations (FEC) has been used as a screening tool for exocrine pancreatic disease in different patient groups indicating a high prevalence of exocrine dysfunction in diabetic populations. "
07/01/2002 - "How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?"
09/01/1998 - "The determination of faecal pancreatic elastase 1 is a reliable test for the diagnosis of chronic pancreatic diseases in man due to its high sensitivity and specificity (93%). "
02/15/1992 - "Abdominal ultrasonographic examination and measurement of serum elastase 1 levels were done within 2 weeks after the initial visit to the clinic in a total of 2098 patients older than 35 years of age with symptoms suggesting pancreatic disease. "
01/01/1992 - "A significant inverse relationship between the binding capacity of alpha 2-M and the activity of the endogenous elastase bound to alpha 2-M was seen in various pancreatic diseases.(ABSTRACT TRUNCATED AT 250 WORDS)"
01/01/1978 - "The purpose of this study was to compare the diagnostic efficacy of endoscopic retrograde pancreatography (ERP) and secretin-CCK test for the diagnosis of pancreatic disease. "
01/01/1976 - "[The pancreatic stimulation test with secretin in the study of chronic pancreatic diseases]."
09/15/1965 - "[Secretin studies in the diagnosis of pancreatic diseases]."
08/01/1950 - "Studies in pancreatic function; a statistical study of pancreatic secretion following secretin in patients without pancreatic disease."
09/01/2006 - "In this article, we illustrate findings of normal pancreas and various pancreatic diseases on magnetic resonance cholangiopancreatography after secretin stimulation."
|7.||Biological Markers (Surrogate Marker)IBA
01/01/2012 - "Improved diagnostic accuracy of pancreatic diseases with a combination of various novel serum biomarkers--case control study from Manipal Teaching Hospital, Pokhara, Nepal."
07/01/2008 - "Despite this, our study clearly demonstrates that urine is a valid source of noninvasive biomarkers in patients with pancreatic diseases."
05/01/2005 - "The purpose of this study was to compare exfoliative bile cytology and biomarkers of the bile in patients with hepatobiliary and pancreatic diseases. "
11/01/2003 - "The anatomic position and relationships of the pancreas make direct observation of pancreatic pathology difficult, so the diagnosis of pancreatic disease is typically based on the measurement of biochemical markers in serum and imaging studies of the abdomen. "
11/01/2015 - "A workshop sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Biomedical Imaging and Bioengineering focused on research gaps and opportunities in the development of new biomarkers of pancreatic disease. "
05/12/1982 - "[Value of the radioimmunologic measurement of serum trypsin in the study of pancreatic diseases. "
08/15/2012 - "Kunitz trypsin inhibitor (KTI) and Bowman-Birk inhibitor (BBI) have trypsin inhibitor activities (TIA), which could cause pancreatic disease if at a high level. "
09/10/2008 - "Soy foods contain significant health-promoting components but also may contain beany flavor and trypsin inhibitor activity (TIA), which can cause pancreatic disease if present at a high level. "
09/15/2006 - "Our biosensor detected low trypsin concentrations down to 42 pM with a response time of approximately 10 min, making it a very sensitive device in the detection of lower trypsin levels with such future putative applications as the diagnosis of pancreatic diseases."
01/01/2000 - "To evaluate trypsin activity in the small intestine of healthy volunteers and patients with pancreatic disease by a recently developed (13)C-egg white breath test. "
|9.||Phospholipases A2 (Phospholipase A2)IBA
06/01/1992 - "This study was performed to investigate the behavior of phospholipase A2 (PLA2) in serum and urine of patients with chronic pancreatic diseases and to ascertain whether any factors influenced the results. "
06/01/1990 - "This study was performed to investigate the phospholipase A2 (PLA2) serum activity in patients with chronic pancreatic disease. "
09/01/1993 - "[Usefulness of serum pancreatic phospholipase A2 determination in patients with various pancreatic diseases]."
04/01/1993 - "Practically no cross-reactivity was seen with partially purified serum phospholipase A2, with recombinant platelet phospholipase A2, or with the sera of patients with non-pancreatic diseases. "
06/01/1992 - "Urinary phospholipase A2 excretion in chronic pancreatic diseases."
03/01/1991 - "Serum pancreatic isoamylase activity in pancreatic disease."
01/01/1991 - "Fecal isoamylase activity in patients with pancreatic diseases."
07/01/1990 - "Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases."
11/01/1988 - "Serum isoamylase activities in pancreatic diseases."
09/01/1983 - "Assessment of a rapid pancreatic isoamylase assay as a screening test for chronic pancreatic disease."
01/01/2005 - "Safety and efficacy of laparoscopic distal pancreatectomy for the treatment of pancreatic disease."
12/01/2013 - "We searched the electronic databases PubMed and EMBASE for studies comparing RP with laparoscopic pancreatectomy (LP) and open pancreatectomy (OP) for patients with pancreatic disease from June 2009 to June 2012. "
12/01/2013 - "A robotic approach to pancreatectomy may be suited to patients with pancreatic disease."
06/01/2013 - "The results of this meta-analysis suggest that robotic pancreatectomy is as safe and efficient as, if not superior to, open surgery for patients with benign or malignant pancreatic diseases. "
06/01/2012 - "In clinical practice, patients with histologically confirmed pancreatic diseases underwent enucleation (n = 2) or distal pancreatectomy with splenic preservation (n = 2). "
01/01/2008 - "Although pancreaticoduodenectomy has become a safe and effective procedure for benign and malignant pancreatic diseases in recent years, leakage of pancreaticoenteric anastomosis still remains a major cause of morbidity and even mortality. "
03/01/2005 - "In the past few years, minimally invasive therapy for pancreatic diseases has made significant strides but the role of laparoscopic pancreaticoduodenectomy is still controversial. "
09/01/1999 - "There have been increasing changes in the role of pancreatoduodenectomy (PD) in the management of benign and malignant pancreatic disease. "
09/01/1997 - "This method has been performed in 35 duodenopancreatectomy (malignant pancreatic disease: 32 patients, benign pancreatic disease: 3 patients). "
06/01/1991 - "Twenty patients underwent a pylorus-preserving pancreatoduodenectomy for benign or malignant periampullary and pancreatic disease. "
|3.||Fat-Restricted Diet (Diet, Fat Restricted)
01/01/2013 - "A low-fat diet may be effective in patients with dyspepsia associated with endosonographic evidence of mild pancreatic disease, who do not habitually drink alcohol."
01/01/2013 - "The objective of this study was to examine the efficacy of low-fat diet against dyspepsia in patients who had endosonographic evidence of nonalcoholic mild pancreatic disease. "
01/01/2013 - "Efficacy of low-fat diet against dyspepsia associated with nonalcoholic mild pancreatic disease diagnosed using the Rosemont criteria."
01/01/2013 - "Patients with unknown cause of upper abdominal pain suggesting pancreatic disease without a history of alcohol consumption were prescribed a low-fat diet (<20 g of fat/d) for 4 weeks. "
12/01/1986 - "The mean values for total fatty acid outputs (after back transformation of the logged data) were significantly higher in each subgroup of patients with pancreatic disease on their usual diets (acute 134, chronic 189, cancer 235 mg) than in the two subgroups of controls (30 and 55 mg), due to significant increases in the outputs of every fatty acid, C16:0 through to C22:5. This finding, which was usually not apparent in patients with pancreatic disease on low-fat diets, may reflect the combined influence of dietary fat intakes and hepatic enzyme induction. "
04/01/2009 - "In recent years, improved laparoscopic skill sets have expanded surgical management of pancreatic disease to encompass pancreatic resection, tumor enucleation, debridement, and drainage. "
10/01/1987 - "A series of seven cases of severe pancreatic disease have been managed by repeat laparotomy for debridement of necrotizing pancreatitis, drainage of abscesses or control of haemorrhage with stapled marlex mesh closure of the abdominal wall. "
|5.||Combination Drug Therapy (Combination Chemotherapy)